Daratumumab-induced acute angle closure glaucoma: bone marrow transplantation as a possible risk factor and atropinization as a potential solution
Abstract This case report describes a 29-year-old female with recurrent T-cell Acute Lymphoblastic Leukemia who developed acute angle closure glaucoma (AACG) following daratumumab infusion. The patient, with a history of bone marrow transplantation and head-neck radiotherapy, experienced sudden eye...
Saved in:
| Main Authors: | Cansu Yuksel Elgin, Ahmet Fırat Atseven, Ofeliya Mammadzada, Özcan Ocakoğlu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Ophthalmology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12886-025-04214-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary Angle Closure Glaucoma : A Review
by: Gaurav Kumar, et al.
Published: (2011-07-01) -
Outcomes and Complications of Minimally Invasive Glaucoma Surgeries (MIGS) in Primary Angle Closure and Primary Angle Closure Glaucoma: A Systematic Review and Meta-Analysis
by: Paik B, et al.
Published: (2025-02-01) -
Atropine in Myopia
by: Priyanka Mishra, et al.
Published: (2021-07-01) -
Bilateral Acute Angle-Closure Glaucoma Induced By Escitalopram
by: Dilbade Yıldız Ekinci, et al.
Published: (2014-10-01) -
Atropine (0.05%) for rapid progressive childhood myopia (ARM study)
by: Rohit Saxena, et al.
Published: (2025-03-01)